1,824
Views
1
CrossRef citations to date
0
Altmetric
Research Article

CircNFIX knockdown inhibited AML tumorigenicity by the miR-876-3p/TRIM31 axis

, , , , &

References

  • Cheng Z, Dai Y, Huang W, et al. Prognostic value of MicroRNA-20b in acute myeloid leukemia. Front Oncol. 2020;10:553344.
  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–1152.
  • Shallis RM, Wang R, Davidoff A, et al. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70–87.
  • Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68:1214–1227.
  • Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44.
  • Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9:4475.
  • Cheng J, Nie D, Li B, et al. CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a -5p. Mol Cell Endocrinol. 2021;525:111140.
  • Ding C, Wu Z, You H, et al. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis. J Exp Clin Cancer Res. 2019;38:506.
  • Lu J, Zhu Y, Qin Y, et al. CircNFIX acts as a miR-212-3p sponge to enhance the malignant progression of non-small cell lung cancer by up-regulating ADAM10. Cancer Manag Res. 2020;12:9577–9587.
  • Guo T, Zhang J, Yao W, et al. CircINHA resists granulosa cell apoptosis by upregulating CTGF as a ceRNA of miR-10a-5p in pig ovarian follicles. Biochim Biophys Acta Gene Regul Mech. 2019;1862:194420.
  • Marcucci G, Mrozek K, Radmacher MD, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117:1121–1129.
  • Peng C, Huang K, Liu G, et al. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3. J Gastroenterol Hepatol. 2019;34:1711–1719.
  • Li Q, Wang Y, Hu R, et al. Dysregulation of SPRR3/miR-876-3p axis contributes to tumorigenesis in non-small-cell lung cancer. Onco Targets Ther. 2020;13:2411–2419.
  • Zhang Z. Silencing LINC00504 inhibits cell proliferation, invasion as well as migration and promotes cell apoptosis in lung cancer cells via upregulating miR-876-3p. Cytotechnology. 2020;72(6):807–817.
  • Mao J, Gao W, Xue L, et al. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway. Int J Lab Hematol. 2021;43:1050–1061.
  • Guo P, Ma X, Zhao W, et al. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Oncogene. 2018;37:478–488.
  • Li H, Zhang Y, Hai J, et al. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway. Biomedic Pharmacother Biomed Pharmacotherapie. 2018;103:1272–1278.
  • Xiao Y, Deng T, Ming X, et al. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling. Biosci Rep. 2020;40(4):BSR20194334.
  • Yu C, Chen S, Guo Y, et al. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Theranostics. 2018;8:3224–3236.
  • Shi G, Lv C, Yang Z, et al. TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway. Neoplasma. 2019;66:727–735.
  • Xiao Y, Deng T, Ming X, et al. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/beta-catenin signaling. Biosci Rep. 2020;40(4):BSR20194334.
  • Tallman MS, Wang ES, Altman JK, et al. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:721–749.
  • Harper KL, McDonnell E, Whitehouse A. CircRNAs: from anonymity to novel regulators of gene expression in cancer (review). Int J Oncol. 2019;55:1183–1193.
  • Rybak-Wolf A, Stottmeister C, Glažar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58:870–885.
  • Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25:1–7.
  • Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267–274.
  • Zhou Z, Sun B, Huang S, et al. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell Death Dis. 2019;10:503.
  • Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions. Development. 2016;143:1838–1847.
  • Wang WB, Ren P, Ren FH, et al. Circ_0000526 blocks the progression of breast cancer by sponging miR-492. Cancer Biother Radiopharm. 2021;36:467–476.
  • Tang Q, Chen Z, Zhao L, et al. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY). 2019;11:9982–9999.
  • Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–388.
  • Panda AC. Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
  • Zhang H, Deng Y, Liang L, et al. Knockdown of TRIM31 enhances colorectal cancer radiosensitivity by inducing DNA damage and activating apoptosis. Onco Targets Ther. 2019;12:8179–8188.
  • Guo Y, Li Q, Zhao G, et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 2021;12:945.
  • Li H, Zhang Y, Zhang Y, et al. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor. Tumour Biol J Int Soc Oncodevelop Biol Medic. 2014;35:5747–5752.
  • Wang H, Yao L, Gong Y, et al. TRIM31 regulates chronic inflammation via NF-kappaB signal pathway to promote invasion and metastasis in colorectal cancer. Am J Transl Res. 2018;10:1247–1259.